Search Results - "Nelson, Craig J."

Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials by Nelson, J. Craig, Papakostas, George I.

“…Objective: The authors sought to determine by meta-analysis the efficacy and tolerability of adjunctive atypical antipsychotic agents in major depressive…”
Get full text

A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression by Nelson, J. Craig, Baumann, Pierre, Delucchi, Kevin, Joffe, Russell, Katona, Cornelius

“…Abstract Background Lithium augmentation of antidepressants for treatment of unipolar major depression was one of the first adjunctive strategies based on a…”
Get full text

Moderators of Outcome in Late-Life Depression: A Patient-Level Meta-Analysis by Nelson, J. Craig, Delucchi, Kevin L., Schneider, Lon S.

“…Age at onset, severity of symptoms, and illness duration are all important moderators in tailoring depression treatment. This meta-analysis found that…”
Get full text

Efficacy of Antidepressants for Late-Life Depression: A Meta-Analysis and Meta-Regression of Placebo-Controlled Randomized Trials by TEDESCHINI, Enrico, LEVKOVITZ, Yeciel, LOVIENO, Nadia, AMERAL, Victoria E, CRAIG NELSON, J, PAPAKOSTAS, George L

“…Late-life depression is an important public health issue, given the growing proportion of the elderly relative to the general population in the developed…”
Get full text

A Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression by Eisendrath, Stuart J, Gillung, Erin, Delucchi, Kevin L, Segal, Zindel V, Nelson, J Craig, McInnes, L Alison, Mathalon, Daniel H, Feldman, Mitchell D

“…Due to the clinical challenges of treatment-resistant depression (TRD), we evaluated the efficacy of mindfulness-based cognitive therapy (MBCT) relative to a…”
Get more information

Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress--preliminary findings by Wolkowitz, Owen M, Mellon, Synthia H, Epel, Elissa S, Lin, Jue, Dhabhar, Firdaus S, Su, Yali, Reus, Victor I, Rosser, Rebecca, Burke, Heather M, Kupferman, Eve, Compagnone, Mariana, Nelson, J Craig, Blackburn, Elizabeth H

“…Depression is associated with an unusually high rate of aging-related illnesses and early mortality. One aspect of "accelerated aging" in depression may be…”
Get full text

Efficacy of Second Generation Antidepressants in Late-Life Depression: A Meta-Analysis of the Evidence by Nelson, J Craig, M.D, Delucchi, Kevin, Ph.D, Schneider, Lon S., M.D

“…Objective Second-generation antidepressants are commonly used to treat major depression in late-life. This systematic review and meta-analysis was undertaken…”
Get full text

A Systematic Review and Meta-analysis of Psychotherapy for Late-Life Depression by Huang, Alice X., M.D., M.S, Delucchi, Kevin, Ph.D, Dunn, Laura B., M.D, Nelson, J. Craig, M.D

“…Objectives To determine the efficacy of psychotherapy in late-life depression and to determine the effect of the type of control group on the magnitude of…”
Get full text

Acute and Long-term Treatment of Late-Life Major Depressive Disorder: Duloxetine Versus Placebo by Robinson, Michael, M.D, Oakes, Tina Myers, Ph.D, Raskin, Joel, M.D, Liu, Peng, Ph.D, Shoemaker, Scarlett, M.S.N, Nelson, J. Craig, M.D

“…Objective To compare the efficacy of duloxetine with placebo on depression in elderly patients with major depressive disorder. Design Multicenter, 24-week…”
Get full text

CLINICAL RELEVANCE OF FATIGUE AS A RESIDUAL SYMPTOM IN MAJOR DEPRESSIVE DISORDER by Fava, Maurizio, Ball, Susan, Nelson, J. Craig, Sparks, JonDavid, Konechnik, Thomas, Classi, Peter, Dube, Sanjay, Thase, Michael E.

“…Residual symptoms of major depressive disorder (MDD) following treatment are increasingly recognized as having a negative impact on the patient because of…”
Get full text

Minor Depression: Is it Important? How Should it be Treated? by Nelson, J. Craig, M.D

Get full text

Feasibility and acceptability of an integrated mind-body intervention for depression: whole-body hyperthermia (WBH) and cognitive behavioral therapy (CBT) by Mason, Ashley E, Chowdhary, Anoushka, Hartogensis, Wendy, Siwik, Chelsea J, Lupesko-Persky, Osnat, Pandya, Leena S, Roberts, Stefanie, Anglo, Claudine, Moran, Patricia J, Nelson, J Craig, Lowry, Christopher A, Patrick, Rhonda P, Raison, Charles L, Hecht, Frederick M

“…To examine the feasibility of an integrated mind-body MDD treatment combining cognitive behavioral therapy (CBT) and whole-body hyperthermia (WBH). In this…”
Get full text

Association of Age at Depression Onset with Cognitive Functioning in Individuals with Late-Life Depression and Executive Dysfunction by Mackin, R. Scott, Ph.D, Nelson, J. Craig, M.D, Delucchi, Kevin L., Ph.D, Raue, Patrick J., Ph.D, Satre, Derek D., Ph.D, Kiosses, Dimitris N., Ph.D, Alexopoulos, George S., M.D, Arean, Patricia A., Ph.D

“…Objective To compare patterns of cognitive performance in older adults with late-onset depression (LOD; ≥65 years of age) with that of older adults with…”
Get full text

Patterns of Reduced Cortical Thickness in Late-Life Depression and Relationship to Psychotherapeutic Response by Mackin, R. Scott, Ph.D, Tosun, Duygu, Ph.D, Mueller, Susanne G., M.D, Lee, Jun-Young, M.D, Insel, Philip, M.S, Schuff, Norbert, Ph.D, Truran-Sacrey, Diana, B.A, Arean, Patricia, Ph.D, Nelson, J. Craig, M.D, Weiner, Michael W., M.D

“…Objective Cortical atrophy has been associated with late-life depression (LLD) and recent findings suggest that reduced right hemisphere cortical thickness is…”
Get full text

Application of the Gradient Boosted method in randomised clinical trials: Participant variables that contribute to depression treatment efficacy of duloxetine, SSRIs or placebo by Dodd, Seetal, Berk, Michael, Kelin, Katarina, Zhang, Qianyi, Eriksson, Elias, Deberdt, Walter, Craig Nelson, J

“…Abstract Background Randomised, placebo-controlled trials of treatments for depression typically collect outcomes data but traditionally only analyse data to…”
Get full text

Cognitive Outcomes After Psychotherapeutic Interventions for Major Depression in Older Adults with Executive Dysfunction by Mackin, R. Scott, Ph.D, Nelson, J. Craig, M.D, Delucchi, Kevin, Ph.D, Raue, Patrick, Ph.D, Byers, Amy, Ph.D, Barnes, Deborah, Ph.D, Satre, Derek D., Ph.D, Yaffe, Kristine, M.D, Alexopoulos, George S., M.D, Arean, Patricia A., Ph.D

“…Objective The purpose of this study was to determine the impact of psychotherapy on cognitive functioning in older adults with late-life depression (LLD) and…”
Get full text

Effects of Baseline Depression Severity on Remission Rates With Duloxetine and Placebo in Anxious and Nonanxious Patients With Major Depression by CRAIG NELSON, J

Get full text

Predictors of relapse in patients with major depressive disorder in a 52-week, fixed dose, double blind, randomized trial of selegiline transdermal system (STS) by Jang, Saeheon, Jung, Sungwon, Pae, Chiun, Kimberly, Blanchard Portland, Craig Nelson, J, Patkar, Ashwin A

“…Abstract Objective We investigated patient and disease characteristics predictive of relapse of MDD during a 52-week placebo controlled trial of selegiline…”
Get full text

Comments on Expectancy, Cognition, and Antidepressant Response in Late Life Depression by Nelson, J. Craig

“…Rutherford et al report a study examining the effects of cognitive impairment on expectancy in late life depression. Rutherford previously conducted a trial in…”
Get full text

Efficacy and safety of adjunctive aripiprazole in major depressive disorder in older patients: a pooled subpopulation analysis by Steffens, David C., Nelson, J. Craig, Eudicone, James M., Andersson, Candace, Yang, Huyuan, Tran, Quynh-Van, Forbes, Robert A., Carlson, Berit X., Berman, Robert M.

“…Objectives To evaluate the efficacy and safety of adjunctive aripiprazole compared with standard antidepressant therapy (ADT) for older patients with major…”
Get full text